Last updated: 2026-02-07 22:44:12 ET
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.
Hims & Hers also said it’s selling a cancer-detection test that’s featured in its Super Bowl ad, which plays like a commentary on the wealthy’s ...
Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was "illegal"
The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started.
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
